PR queen Roxy Jacenko hospitalised after Ozempic overdose
Aussie PR queen Roxy Jacenko has opened up about the time she overdosed on a weight-loss medicine and ended up in a hospital drug unit for three days.
The 45-year-old mother-of-two told The Daily Telegraph that she nearly died after injecting four times the prescribed amount of Ozempic.
'I would never in my life… do Ozempic again,' she said.
'I have never ever ever felt so violently ill. I swear to you, I remember laying in my bed… Oli (Jacenko's husband) kept feeding me jelly beans.
'I thought I was going to die. I thought: 'this is it'. I couldn't even wait for an ambulance.
'I did it when it was very new. But I did take four times the amount I was meant to.
'I can assure you the drug overdose unit for three days is not a pretty place to be.'
Ozempic is an injection consisting of an active ingredient called Semaglutide. It was originally created to help people with type two diabetes manage their blood sugar levels.
However, doctors started prescribing it to help those struggling with their weight.
The increase in its use resulted in a nationwide shortage, meaning people with diabetes were unable to access a medicine they needed to survive.
To fix the Ozempic shortage, a new product called Wegovy was added to the market.
Wegovey uses the exact same active ingredient as Ozempic, however, it is approved by the TGA to be prescribed for chronic weight management.
Since her unpleasant experience with Ozempic, Jacenko has lost 18 kilograms being on a strict diet and fasting after 6.30pm.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Herald Sun
10 hours ago
- Herald Sun
WWE icon The Undertaker reveals ‘terrifying' heart condition he never knew he had
Don't miss out on the headlines from Sport. Followed categories will be added to My News. WWE legend The Undertaker has bravely opened up about how a lifesaving heart operation helped him escape death. The Hall of Fame wrestler, whose real name is Mark Calaway, retired back in 2020 after one of the most legendary careers in sport's entertainment. Watch the biggest Aussie sports & the best from overseas LIVE on Kayo Sports | New to Kayo? Get your first month for just $1. Limited time offer. He was a staple piece of WWE for decades and has since continued to give back through his Six Feet Under podcast and ambassadorial role for the company. In the weeks leading up to the WrestleMania 41 weekend in April, Calaway was quietly battling something far more real than the on-screen storylines of the wrestling world. According to his wife Michelle McCool, the warning signs began in March, when routine cardiac tests flagged something off with her husband's heart, The Sun reports. Follow-up checks revealed Taker had likely been in chronic atrial fibrillation (AFib) for an unknown length of time. The 60-year-old had no noticeable symptoms beyond occasional breathlessness — something he'd chalked up to nothing serious. He was eventually hospitalised for four nights with an ejection fraction (a measure of how much blood the heart pumps with each beat) of just 30 per cent — a dangerously low number for a man of his size and age. And yet, even with his heart rate unstable, Taker insisted on going to WrestleMania two weeks later, to be there for McCool's Hall of Fame induction — and to induct her personally. McCool, a two-time WWE Women's Champion, said on the Six Feet Under podcast: 'You weren't supposed to go anywhere. You didn't want me to tell anybody. 'That's that old school mentality. I'm not mad at it — because I'd probably be the same patient — but it was terrifying. 'The next morning after returning home from WrestleMania, we were in the hospital in Las Vegas at 6am for a little bit of heart surgery.' Taker, whose older brother died from a heart attack in 2020, then begrudging admitted: 'I wasn't supposed to go to Vegas.' McCool, who is Taker's third wife, added: 'You didn't want me to tell anybody. I couldn't focus on anything else. 'All I wanted to focus on was you, your heart, getting the best cardiologists, a lot of phone calls, several nights in the hospital. And by the grace of God, you are here. 'But out of the words of the doctor himself 'it could have turned out badly if we had not found out that very day'.' Taker then coyly joked: 'Yeah, well now I'm as strong as a Bull.' Before McCool, who is 15 years his junior, joked back: 'And thankfully you can still pretend that you're a dead man. Because I saved your life.' This article originally appeared in the The Sun and was reproduced with permission Originally published as The Undertaker reveals 'terrifying' heart condition he never knew he had
Perth Now
a day ago
- Perth Now
Weight loss jabs could be dished out like statins
Weight loss injections could be handed out like statins. Professor Sir Stephen Powis, a medical director of NHS England, thinks the jabs will become cheaper in the future, and they will be used to lower people's risks of getting an illness. His belief comes as it was recently revealed that weight loss jabs could cut the risk of obesity-related cancers. Experts in Israel analysed data from 6,356 people - with around half of the volunteers having had bariatric surgery, which modifies the digestive system to lower food intake, and the rest took slimming jabs - and after an average follow-up of 7.5 years, 298 patients were found to have had obesity-related cancers. Weight-loss jabs, or GLP-1-based medicines, such as tirzepatide - act like the glucose hormone GLP-1 by decreasing appetite and increasing feelings of fullness. And researchers, who presented the findings - which are in the journal eClinicalMedicine - at the European Congress on Obesity in Malaga, Spain, said "new generation, highly potent GLP1-RAs with higher efficacy in weight reduction" such as Wegovy, can produce could result in an "even greater advantage" of reducing obesity-related cancers. Prof Powis told The Sun newspaper: "I think, over time, it's highly likely they will become more widespread. "I think there will be a combination of increased evidence of positive outcomes and cost dropping."
Sky News AU
3 days ago
- Sky News AU
Choice sunscreen test finds most brands do not meet SPF 50 claims
Major sunscreen brands are not living up to their SPF claims, according to a new test from consumer group Choice. Choice tested 20 popular SPF50 and SPF50+ sunscreens and found that only four lived up to the standard they claimed, with 16 falling short. SPF stands for 'sun protection factor' and is the measure of how well the sunscreen protects from the sun's UV rays. An SPF 50 sunscreen is meant to block about 98 per cent of the rays, meaning it will take 50 times longer to get burnt than with unprotected skin. The consumer group tested the products with experts in an accredited sunscreen lab, with four products returning SPF results in the 40s, four in the 30s, and seven in the 20s. Choice chief executive Ashley de Silva said the tests showed that products were not meeting consumer expectations. 'Consumers expect sunscreen to protect them in line with the SPF rating on the product, but as our testing has shown, the SPF label doesn't always match what's in the bottle,' he said. One sunscreen, Ultra Violette's lean screen SPF 50+ mattifying zinc skinscreen, astoundingly returned a result of just SPF4. 'We were really shocked to see the results for Ultra Violette's lean screen SPF 50+ product, so much so that we actually decided to test a different batch at a completely different lab in Germany to confirm the results,' Mr de Silva said. 'Those tests found the product had an SPF of 5 – an almost identical result to our initial testing.' The consumer group was, however, quick to remind people that while a sunscreen may have ranked lower than claimed in its tests, that does not mean that products do not work. A sunscreen with an SPF of 30 or 20 can still give significant sun protection and is much better than using no sunscreen at all. Choice have told the Therapeutic Goods Administration (TGA) and Australian Competition and Consumer Commission (ACCC) about the results of the tests and asked the TGA to conduct their own tests. 'Risk of death': Grim call on Temu itemsAussies warned over new pay trend 'Choice is calling on the TGA to urgently carry out its own sunscreen compliance testing and on the ACCC to investigate if any SPF claims are misleading,' Mr de Silva said. 'Currently, the TGA relies on reports provided by manufacturers to ensure the safety, quality and efficacy of sunscreen products. 'Unfortunately, these reports may not be providing the accurate information consumers need when choosing sunscreens for themselves and their families.' Originally published as Consumer group finds most sunscreens do not meet SPF claims
